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Dear Sirs,
Increasing evidence supports the association between the 
novel severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2), the etiologic agent of the coronavirus dis-
ease 2019 (COVID-19), and neurological complications, 
including encephalopathy, encephalitis, Guillain–Barré 
syndrome, and cerebrovascular disease [1, 2]. In particu-
lar, both ischemic and hemorrhagic strokes have been 
linked to COVID-19 [3–5]. Since a substantial proportion 
of these reported patients had associated vascular risk fac-
tors, it is crucial to determine whether this association is 
causal or coincidental [1, 3, 6]. In an effort to systemati-
cally assess this issue, Shtaya et al. proposed to classify 
cases of COVID-19-related stroke in three major groups: 
(1) hospital acquired; (2) community acquired; (3) stroke 
as direct complications of COVID-19 [7]. Most of the cases 
of our report [3] and other series [4, 5] fulfill the criteria for 
the latter group as defined by the authors. Conversely, we 
did not encounter hospital-acquired COVID-19 infections 
in patients hospitalized for stroke, since protective meas-
ures were readily implemented in our institutions. Although 
we believe that this proposed classification is valuable in 
highlighting a relevant clinical problem, these definitions 
are based on both epidemiological data (location of infec-
tion, as for pneumonia, difficult to ascertain in real-life set-
tings) and pathogenetic aspects (as in group 3, for which 
few information is available at the moment), making their 
use impractical. Moreover, we believe that it is possible that 
some patients can fit two of the proposed categories (e.g., 
patients with community-acquired COVID-19 can develop 
stroke as direct complication of SARS-CoV-2). Ellul et al. 
suggested an alternative classification, subdividing cases 
with “probable” (SARS-CoV-2 identified, lack of vascular 
risk factors) and “possible” (when vascular risk factors are 
present) association [1]. We suggest some adaptations of the 
latter case definition as emerging data have shown distinct 
stroke patterns in COVID-19 infection [3–5, 8]. These fea-
tures (clinical, laboratory, and pathological characteristics, 
shown in the Table 1) can provide supporting evidence in 
favor of a link in doubtful cases.
We propose a revised definition of CAS, with three 
degrees of certainty (possible, probable, and confirmed, 
as illustrated in the Table 1). Even if the World Health 
Organization (WHO) has provided definition for sus-
pected, probable, and confirmed COVID-19 cases, we 
believe that only patients with laboratory-confirmed 
SARS-CoV-2 should enter in the classification, in addition 
to clinic-radiological evidence of acute stroke (ischemic 
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or hemorrhagic). These two represent the major criteria 
of this revised definition. Minor criteria were designed 
to capture additional evidence of a causal and biologi-
cally plausible association: (1) onset of stroke few days to 
3 weeks after COVID-19 symptoms [3–5],(2) lack of car-
diovascular risk factors [1, 8],(3) D-dimer and/or lactate 
dehydrogenase elevation [3–5]. The presence of at least 
one of these features is required for “possible CAS”, and 
two for “probable CAS”, while confirmed CAS requires 
pathological evidence of disappearance of endothelial cells 
in the affected arterioles, capillaries and venules. These 
findings reflect the pathogenesis of CAS, which involves 
a thrombotic microangiopathy caused by endotheliopathy 
[4, 9]. Some additional features, such as the detection of 
SARS-CoV-2 in the cerebrospinal fluid (CSF), can pos-
sibly provide additional evidence of a causal association, 
although cases with negative CSF have been described 
[10]. Therefore, we do not believe that this represents a 
necessary feature.
It is important to notice that the absence of the typical 
clinical patterns of CAS should question the diagnosis. Typ-
ical clinical features of COVID-19-related stroke include 
large vessel occlusion, multi-territory involvement, and 
posterior circulation predisposition (Fig. 1a–g) [3–5, 8]. In 
addition, less frequent presentations were also observed: 
onset with seizures and/or encephalopathy [3, 4], extra-cra-
nial dissection [4, 11, 12], including bilateral carotid artery 
dissection [12] (Fig. 1h–j), and posterior reversible encepha-
lopathy (PRES) [4] or laminar cortical damage [13]. 
Interestingly, if we retrospectively apply the CAS crite-
ria to the 12 patients with community-acquired COVID-19 
reported by Shtaya et al. [7], 3 of their cases do not fulfill 
the major criteria (neuroimaging not performed). Among the 
other nine patients, stroke developed few days to 3 weeks 
later in all cases (criteria for possible CAS fulfilled) and in 
two, there were no known vascular risk factors (criteria for 
probable CAS fulfilled). In particular, case 12 was a previ-
ously healthy 50-year-old man who developed a posterior 
circulation stroke 3 days after the onset of COVID-19 symp-
toms in the context of vertebral artery dissection [7], consist-
ent with our proposed definition. This example suggests that 
the CAS criteria can be useful in identifying stroke cases 
more likely to be causally linked to COVID-19, irrespective 
of where the infection was acquired.
Development of a standardized case definition for stroke 
of presumed infectious etiology related to SARS-CoV-2 is 
important for epidemiological surveillance, clinical research, 
outbreak investigations, as well as for allocation of health-
care resources. As the understanding of this novel disease is 
expanding rapidly, the proposed definition will likely need 
refining as more data emerge. Nevertheless, this proposal 
represents a first step into harmonization of research studies 
into the topic of CAS.
Table 1  Proposed case 
definition of COVID-19-
associated stroke (CAS)
COVID-19 coronavirus disease 2019, CSF cerebrospinal fluid, LDH lactate dehydrogenase, PCR polymer-
ase chain reaction, PRES posterior reversible encephalopathy syndrome, SARS-CoV-2 severe acute respira-
tory syndrome coronavirus 2
Case definition
Major criteria
1. Clinical and neuroradiological evidence of acute stroke (ischemic or hemorrhagic)
2. SARS-CoV-2 detection by PCR testing OR detection of SARS-CoV-2-specific antibody in serum indi-
cating acute infection
Minor criteria
1. Timing of onset (from few days to 3 weeks after COVID-19 symptoms)
2. Lack of cardiovascular risk factors
3. D-dimer and/or LDH elevation
Possible CAS: 2 major criteria and 1 minor criterion
Probable CAS: 2 major criteria and ≥ 2 minor criteria
Confirmed CAS: criteria for probable CAS and consistent pathologic  findings*
Note: the absence of the typical clinical patterns of  CAS** should question the diagnosis
Clinical supporting  features**
1. Large vessel occlusion
2. Vertebrobasilar location
3. Multi-territory involvement
4. Onset with seizures
5. Extra-cranial dissection
6. PRES or laminar cortical damage
Pathologic supporting  features*
Evidence of endothelial disruption
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Fig.1  Neuroimaging features of COVID-19-associated stroke. a A 
70-year-old man with critical COVID-19-related ARDS developed 
acute right-sided weakness. Brain CT showed a large fronto-insular 
ischemic lesion within the vascular territory of the left middle cer-
ebral artery. b A 64-year-old man with COVID-19 infection devel-
oped multi-organ failure. Brain CT showed multiple recent ischemic 
lesions involving cortical-subcortical regions of both parietal lobes 
and centrum semiovale. c–e A 67-year-old man with COVID-19 and 
critical ARDS presented myocardial infarction 2 days after hospitali-
zation. On day 14, he developed a tetraparesis. Brain and spine MRI 
were requested. As an incidental finding (given the final diagnosis of 
critical illness neuropathy), brain MRI showed a left parieto-occipi-
tal infarction, hyperintense on T1-weighted images (c) and bright on 
DWI (d) along the cortex, with subcortical white matter perilesional 
edema on FLAIR sequence (e). f–g A 72-year-old man diagnosed 
with COVID-19 presented with ataxia and vomiting. MRI showed 
infarction of the postero-inferior part of the left cerebellar hemisphere 
and the inferior part of the vermis in the territory of PICA (f, coronal 
FLAIR). Areas of hypointensity within the vermis, corresponding to 
blood degradation products, were also noted. The lesion underwent 
extensive hemorrhagic transformation with large parenchymal hema-
toma (g, axial CT). h–j A 58-year-old man with moderate COVID-
19 presented with intense headache and neck pain. h CT angiogra-
phy showed a long stenosis of the distal part of internal carotid artery 
bilaterally. MRI axial T1-weighted images obtained with fat satura-
tion (i) and T2-weighted images (j) showed a narrowed eccentric flow 
void surrounded by a crescent-shaped subacute mural hematoma. 
This case of bilateral carotid dissection was previously reported by 
our group [12]. ARDS acute respiratory distress syndrome, CT com-
puted tomography, DWI diffusion-weighted imaging, FLAIR fluid-
attenuated inversion recovery, MRI magnetic resonance imaging, 
PICA posterior inferior cerebellar artery
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